Comprehensive microRNA expression profiling in cerebrospinal fluid distinguishes between neurological disease classes

Neuropathol Appl Neurobiol. 2019 Apr;45(3):318-323. doi: 10.1111/nan.12491. Epub 2018 May 21.

Affiliations

¹ Department of Internal Medicine III, Ulm University Hospital, Ulm, Germany.
² Institute of Experimental Cancer Research, Ulm University, Ulm, Germany.
³ Department of Neurology, Ulm University, Ulm, Germany.
⁴ Department of Hematology, Oncology, Palliative Care and Infectious Diseases, Alb-Fils-Kliniken, Göppingen, Germany.
⁵ Erasmus University Medical Center, Rotterdam, Netherlands.
⁶ DKFZ, Mechanisms of Leukemogenesis, Heidelberg, Germany.

PMID: 29679382
DOI: 10.1111/nan.12491

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Atlases as Topic
Biomarkers / cerebrospinal fluid*
Central Nervous System Diseases / cerebrospinal fluid*
Central Nervous System Diseases / diagnosis*
Cohort Studies
Humans
MicroRNAs / cerebrospinal fluid*
Sequence Analysis, RNA

Substances

Biomarkers
MicroRNAs